Chenxia Hu
Impact in
- Molecular Medicine top 5%
- Curcumin's Biomedical Applications
- Genetics top 10%
- Mesenchymal stem cell research
Papers in
-
- RNA Interference and Gene Delivery 2
- Oncology 6
- Cancer Cells and Metastasis 4
- Colorectal Cancer Treatments and Studies 1
- Co-authors
- Mengjie Li (7 shared papers)Shaoxi Wang (3 shared papers)Tingting Guo (4 shared papers)Fengxue Zhang (2 shared papers)Yujian Wu (4 shared papers)Jiayi Lin (4 shared papers)Lijun Chen (1 shared paper)Xiaowei Xu (1 shared paper)
- Journals
- Annals of Oncology (2 papers)BioMed Research International (2 papers)OncoTargets and Therapy (1 paper)Biochemical Pharmacology (1 paper)Journal of Magnetic Resonance Imaging (1 paper)
- Partner nations
- ChinaCanadaUnited States
In The Last Decade
Chenxia Hu
19 papers receiving 659 citations
Chenxia Hu's Hit Papers
Peers
Comparison fields: 5 of 95
- Molecular Medicine 84
- Genetics 114
- Cancer Research 91
- Neurology 89
- Infectious Diseases 86
Countries citing papers authored by Chenxia Hu
This map shows the geographic impact of Chenxia Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chenxia Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chenxia Hu more than expected).
Fields of papers citing papers by Chenxia Hu
This network shows the impact of papers produced by Chenxia Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chenxia Hu. The network helps show where Chenxia Hu may publish in the future.
Co-authors
The 25 scholars most cited alongside Chenxia Hu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Clinical Study of Mesenchymal Stem Cell Treatment for Acute Respiratory Distress Syndrome Induced by Epidemic Influenza A (H7N9) Infection: A Hint for COVID-19 Treatment Hit paper breakdown → | 2020 | 195 |
| 2 | 2018 | 115 | |
| 3 | 2021 | 76 | |
| 4 | 2018 | 60 | |
| 5 | 2015 | 59 | |
| 6 | 2018 | 50 | |
| 7 | 2019 | 27 | |
| 8 | 2020 | 25 | |
| 9 | 2021 | 18 | |
| 10 | 2010 | 15 | |
| 11 | 2021 | 6 | |
| 12 | 2022 | 5 | |
| 13 | 2018 | 4 | |
| 14 | 2018 | 4 | |
| 15 | 2024 | 2 | |
| 16 | 2017 | 2 | |
| 17 | 2024 | 2 | |
| 18 | 2025 | 1 | |
| 19 | Effects of Herbal Tea of Guangdong on Expression of HSP70 in Liver Tissues of Heat Shock Rats | 2008 | 1 |
| 20 | 2024 | 0 |
About Chenxia Hu
Chenxia Hu is a scholar working on Molecular Biology, Oncology, Biomedical Engineering, Surgery and Cancer Research, having authored 20 papers that have together received 667 indexed citations. Recurring topics across this work include Cancer Cells and Metastasis (4 papers), MicroRNA in disease regulation (3 papers), Nanoplatforms for cancer theranostics (3 papers), Hippo pathway signaling and YAP/TAZ (2 papers), Curcumin's Biomedical Applications (2 papers), RNA Interference and Gene Delivery (2 papers), Mesenchymal stem cell research (1 paper) and Colorectal Cancer Treatments and Studies (1 paper). The work is most often cited by research in Molecular Medicine (84 citations), Genetics (114 citations), Cancer Research (91 citations), Neurology (89 citations) and Infectious Diseases (86 citations). Chenxia Hu has collaborated with scholars based in China, Canada and United States. Frequent co-authors include Mengjie Li, Shaoxi Wang, Tingting Guo, Fengxue Zhang, Yujian Wu, Jiayi Lin, Lijun Chen, Xiaowei Xu, Lü Chen and Xiahong Dai. Their work appears in journals such as Annals of Oncology, BioMed Research International, OncoTargets and Therapy, Biochemical Pharmacology and Journal of Magnetic Resonance Imaging.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.